These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 4940315)

  • 1. The UGDP study.
    Salsburg DS
    JAMA; 1971 Dec; 218(11):1704-5. PubMed ID: 4940315
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
    Knatterud GL; Meinert CL; Klimt CR; Osborne RK; Martin DB
    JAMA; 1971 Aug; 217(6):777-84. PubMed ID: 4935344
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.
    Meinert CL; Knatterud GL; Prout TE; Klimt CR
    Diabetes; 1970; 19():Suppl:789-830. PubMed ID: 4926376
    [No Abstract]   [Full Text] [Related]  

  • 4. The UGDP--tolbutamide and mortality.
    Knowles HC
    Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432
    [No Abstract]   [Full Text] [Related]  

  • 5. Comments on the UGDP study.
    Schöffling K
    Horm Metab Res; 1974; Suppl 4():188-91. PubMed ID: 4608018
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report.
    Diabetes; 1982 Nov; 31 Suppl 5():1-81. PubMed ID: 6757026
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy of type 2 diabetes, cardiovascular death, and the UGDP.
    Feinglos MN; Bethel MA
    Am Heart J; 1999 Nov; 138(5 Pt 1):S346-52. PubMed ID: 10539796
    [No Abstract]   [Full Text] [Related]  

  • 8. The University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of pheniformin therapy.
    Diabetes; 1975; 24 Suppl 1():65-184. PubMed ID: 1090475
    [No Abstract]   [Full Text] [Related]  

  • 9. [Causes of death in diabetes mellitus].
    Akhmetzianov AM; Mazovetskiĭ AG; Kliachko VR
    Probl Endokrinol (Mosk); 1975; 21(1):103-11. PubMed ID: 1094446
    [No Abstract]   [Full Text] [Related]  

  • 10. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 11. A prospective view of the treatment of adult-onset diabetes with special reference to the University Group Diabetes Program and oral hypoglycemic agents.
    Prout TE
    Med Clin North Am; 1971 Jul; 55(4):1065-75. PubMed ID: 4946757
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenformin and vascular complications of diabetes.
    Med Lett Drugs Ther; 1972 Jan; 14(1):1-2. PubMed ID: 4567560
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP results.
    Goldner MG; Knatterud GL; Prout TE
    JAMA; 1971 Nov; 218(9):1400-10. PubMed ID: 4941698
    [No Abstract]   [Full Text] [Related]  

  • 14. The crux of the UGDP. Spurious results and biologically inappropriate data analysis.
    Kilo C; Miller JP; Williamson JR
    Diabetologia; 1980 Mar; 18(3):179-85. PubMed ID: 6989693
    [No Abstract]   [Full Text] [Related]  

  • 15. A progress report on the University Group Diabetes Program.
    Prout TE
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):244-51. PubMed ID: 809369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report of the Committee for the Assessment of Biometric Aspects of Controlled Trials of Hypoglycemic Agents.
    JAMA; 1975 Feb; 231(6):583-608. PubMed ID: 1089822
    [No Abstract]   [Full Text] [Related]  

  • 17. [Increased risk of cardiovascular complications with oral hypoglycemic agents?].
    Mueller R
    Acta Diabetol Lat; 1970; 7(5):805-23. PubMed ID: 4949515
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapy of early diabetes. The University Group Diabetes Program.
    Prout TE
    Adv Metab Disord; 1973; 2():Suppl 2:501-20. PubMed ID: 4720381
    [No Abstract]   [Full Text] [Related]  

  • 19. Antidiabetic agents and vascular events.
    Keen H
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():99-105. PubMed ID: 783218
    [No Abstract]   [Full Text] [Related]  

  • 20. The UGDP controversy. Clinical trials versus clinical impressions.
    Prout TE; Knatterud GL; Meinert CL; Klimt CR
    Diabetes; 1972 Oct; 21(10):1035-40. PubMed ID: 4561330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.